Open AccessPersonalizing medicine through targeted agents, capitalizing on pathway dysregulation and biomarker use
Author(s) -
Kim M. Hirshfield
Publication year - 2008
Publication title -
personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.489
H-Index - 31
eISSN - 1744-828X
pISSN - 1741-0541
DOI - 10.2217/17410541.5.6.575
Subject(s) - medicine , personalized medicine , biomarker , precision medicine , imatinib , prostate cancer , cancer , chronic myelogenous leukemia , targeted therapy , clinical trial , oncology , bioinformatics , cancer research , leukemia , biology , genetics , pathology , myeloid leukemia